-+ 0.00%
-+ 0.00%
-+ 0.00%

Cognition Therapeutics Q2 EPS $(0.04) Beats $(0.06) Estimate

Benzinga·08/06/2026 21:13:43
Listen to the news
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 63.64 percent increase over losses of $(0.11) per share from the same period last year.